It has been reported that increased infiltration of T cells could enhance antitumor immunity and increase the sensitivity of anti-PD-L1 immunotherapy, resulting in the satisfy outcomes for HCC patients [51, 52]. The gene discussed is CD274; the disease is hepatocellular carcinoma.